Work

Abstract 924: The androgen receptor antagonist darolutamide shows strong antitumor efficacy in patient- and cell line-derived xenograft prostate cancer models

Year: 2019

Type: conference-abstract

DOI: 10.1158/1538-7445.sabcs18-924

Authors: Pascale Lejeune, Antje Wengner, Simon J. Baumgart, Ekaterina Nevedomskaya, Eva Corey, Dominik Mumberg, Bernard Haendler

Institutions: Bayer (Germany), University of Washington

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2955440919

Cites:

Cited by:

Related to: 10